Biomerica CFO reports multiple stock option grants

Newly reported finance executive at BIOMERICA INC discloses several existing multi-year stock option awards in a Form 3 filing.

Rhea-AI Filing Summary

BIOMERICA INC (BMRA) filed an initial insider ownership report for Qu Xiaoxuan, who serves as Principal Financial Officer and Principal Accounting Officer. The filing lists existing stock option awards covering 4,300 shares at $2.13, 4,188 shares at $2.64, 1,875 shares at $7.28, and 1,000 shares at $9.44, all for common stock. These options vest in four equal annual installments beginning on dates from August 21, 2024 through April 10, 2027, subject to continued service, and any vested options expire 90 days after the officer’s termination, with final expiration dates between August 21, 2033 and April 10, 2036.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Qu Xiaoxuan

Role See Remarks

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy) F1	--	--	--
holding	Stock Option (Right to Buy) F2	--	--	--
holding	Stock Option (Right to Buy) F3	--	--	--
holding	Stock Option (Right to Buy) F4	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 11,363 contracts (Direct)

Footnotes (4)

1. F1. The option vests in four equal annual installments beginning on April 10, 2027, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
2. F2. The option vests in four equal annual installments beginning on January 9, 2026, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
3. F3. The option vests in four equal annual installments beginning on January 18, 2025, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
4. F4. The option vests in four equal annual installments beginning on August 21, 2024, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

Key Figures

Option exercise price: $2.13 per share Underlying shares at $2.13: 4,300 shares Option exercise price: $2.64 per share +5 more

8 metrics

Option exercise price $2.13 per share Stock option on 4,300 shares of common stock expiring April 10, 2036

Underlying shares at $2.13 4,300 shares Common stock subject to a stock option held directly by the officer

Option exercise price $2.64 per share Stock option on 4,188 shares of common stock expiring January 9, 2035

Underlying shares at $2.64 4,188 shares Common stock subject to a stock option held directly by the officer

Option exercise price $7.28 per share Stock option on 1,875 shares of common stock expiring January 18, 2034

Underlying shares at $7.28 1,875 shares Common stock subject to a stock option held directly by the officer

Option exercise price $9.44 per share Stock option on 1,000 shares of common stock expiring August 21, 2033

Underlying shares at $9.44 1,000 shares Common stock subject to a stock option held directly by the officer

Key Terms

stock option, vesting, exercise price, expiration date

4 terms

stock option financial

"The filing lists existing stock option awards covering common stock."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vesting financial

"Each option vests in four equal annual installments, subject to continued service."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"Each reported option has a stated exercise price per share of common stock."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"The options have expiration dates between August 21, 2033 and April 10, 2036."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

What does the Form 3 filing for BMRA disclose about Qu Xiaoxuan?

The Form 3 for BMRA reports that Qu Xiaoxuan, the Principal Financial Officer and Principal Accounting Officer, holds several existing stock options on common stock, each with specified exercise prices, share amounts, vesting schedules over four years, and expiration dates through April 10, 2036.

How many BIOMERICA INC (BMRA) shares are covered by Qu Xiaoxuan’s $2.13 stock option?

One stock option held by Qu Xiaoxuan covers 4,300 shares of BIOMERICA INC common stock at an exercise price of $2.13 per share, with options vesting in four equal annual installments starting April 10, 2027, subject to continued service, and expiring on April 10, 2036.

What are the main terms of the $2.64 stock option reported for BMRA?

The filing shows a stock option for 4,188 shares of BIOMERICA INC common stock with an exercise price of $2.64 per share, vesting in four equal annual installments beginning January 9, 2026, subject to continued service, and expiring on January 9, 2035, with vested options ending 90 days after termination.

What higher-price stock options does the BMRA officer hold?

Qu Xiaoxuan holds options on 1,875 shares at $7.28 per share expiring January 18, 2034, and 1,000 shares at $9.44 per share expiring August 21, 2033. Each vests in four equal annual installments from January 18, 2025 and August 21, 2024, respectively, subject to continued service.

Are there any immediate share purchases or sales in this BMRA Form 3?

No. The Form 3 for BMRA reports existing direct holdings of stock options by the officer. It does not report any purchases, sales, or exercises; it simply discloses the outstanding option awards and their vesting and expiration terms as of the reporting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:30 PM Accepted by SEC EDGAR 09/08/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Qu Xiaoxuan

(Last) (First) (Middle)

17571 VON KARMAN AVE

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
BIOMERICA INC [ BMRA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	04/10/2036	Common Stock	4,300	$2.13	D
Stock Option (Right to Buy)	(2)	01/09/2035	Common Stock	4,188	$2.64	D
Stock Option (Right to Buy)	(3)	01/18/2034	Common Stock	1,875	$7.28	D
Stock Option (Right to Buy)	(4)	08/21/2033	Common Stock	1,000	$9.44	D

Explanation of Responses:

1. The option vests in four equal annual installments beginning on April 10, 2027, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

2. The option vests in four equal annual installments beginning on January 9, 2026, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

3. The option vests in four equal annual installments beginning on January 18, 2025, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

4. The option vests in four equal annual installments beginning on August 21, 2024, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.

Remarks:

Principal Financial Officer and Principal Accounting Officer

	/s/ Xiaoxuan Qu	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)